(2013) 305:C44756
What the call will fund The ECTC supports early-phase trials testing a range of interventions, including small molecules (including repurposed drugs), advanced therapy medicinal products (ATMPs) with GMP-validated manufacturing appropriate for Phase I/II, biologics and new biological entities, and repurposed biologics
[DOI] [PubMed] [Google Scholar] 130.Shimizu H., Kiyohara Y., Kato I., Kitazono T., Tanizaki Y., Kubo M., Ueno H., Ibayashi S., Fujishima M., Iida M
For the scalp specifically, the structural improvements to follicular environments may provide more durable results, though research on long-term maintenance remains ongoing
"Arsenic methylation, urinary arsenic metabolites and human diseases: current perspective"